In a filing, Arbutus Biopharma Corp revealed its Officer Sofia Michael J. acquired Company’s shares for reported $0.34 million on Mar 13 ’25. In the deal valued at $3.38 per share,100,000 shares were bought.
Then, Sofia Michael J. bought 167,162 shares, generating $549,963 in total proceeds.
Before that, HASTINGS DAVID C sold 22,183 shares. Arbutus Biopharma Corp shares valued at $72,827 were divested by the Chief Financial Officer at a price of $3.28 per share. As a result of the transaction, HASTINGS DAVID C now holds 159,724 shares, worth roughly $0.51 million.
Jefferies upgraded its Arbutus Biopharma Corp [ABUS] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late February with a ‘”a Hold”‘ rating. H.C. Wainwright began covering ABUS with “Buy” recommendation on December 17, 2020.
Price Performance Review of ABUS
On Tuesday, Arbutus Biopharma Corp [NASDAQ:ABUS] saw its stock fall -2.44% to $3.20. Over the last five days, the stock has gained 4.58%. Arbutus Biopharma Corp shares have fallen nearly -2.14% since the year began. Nevertheless, the stocks have risen 22.61% over the past one year. While a 52-week high of $4.72 was reached on 02/25/25, a 52-week low of $2.30 was recorded on 03/12/25. SMA at 50 days reached $3.33, while 200 days put it at $3.59.
Levels Of Support And Resistance For ABUS Stock
The 24-hour chart illustrates a support level at 3.15, which if violated will result in even more drops to 3.10. On the upside, there is a resistance level at 3.26. A further resistance level may holdings at 3.32. The Relative Strength Index (RSI) on the 14-day chart is 43.76, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 67.27%. Stochastics %K at 40.39% indicates the stock is a holding.
How much short interest is there in Arbutus Biopharma Corp?
A steep rise in short interest was recorded in Arbutus Biopharma Corp stocks on 2025-02-28, growing by 1.69 million shares to a total of 8.41 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 6.72 million shares. There was a rise of 20.08%, which implies that there is a positive sentiment for the stock.
